Table 2 Clinical Manifestations of the Patients and Laboratory Test Results.

From: Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome

Clinical manifestation

Patients with PA-SOS

n/N (%)

hepatomegaly

18/25 (72.00%)

ascites

25/25 (100%)

jaundice

16/25 (64%)

Laboratory tests*

Mean ± SD

erythrocytes

4.61 ± 0.49

HGB

135.92 ± 16.16

leukocytes

5.94 ± 1.63

PLT

95.52 ± 37.07

ALT

103.56 ± 123.27

AST

155.56 ± 166.00

ALP

153.04 ± 67.00

γ-GT

139.44 ± 95.24

total bilirubin

49.46 ± 33.29

albumin

34.02 ± 4.34

PT

17.28 ± 3.42

INR

1.45 ± 0.34

Cr

83.68 ± 37.72

BUN

7.57 ± 3.91

  1. *Normal ranges for the laboratory test results: erythrocytes: 3.0–5.5 × 1012/L, hemoglobin: 110–160 g/L, leukocytes: 4–10 × 109/L, platelets: 100–300 × 109/L, alanine aminotransferase (ALT): 5–35 U/L, aspartate aminotransferase (AST): 8–40 U/L, alkaline phosphatase (ALP) 40–150 U/L, albumin: 35–55 g/L, total bilirubin: 5.1–19 μmol/L, γ-glutamyl-transferase (γ-GT) 7–32 U/L, prothrombin time (PT): 11–16 s, creatinine: 44–106 μmol/L, blood urea nitrogen (BUN): 1.8–7.1 mmol/L.